We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
INTEGRA BIOSCIENCES AG

Download Mobile App




In Other News

Image: CN-3000 and CN-6000 automated hemostasis analyzers for mid- and high‑volume laboratories are now available for patient testing in the United States. (Photo courtesy of Siemens Healthineers)

New Automated Hemostasis Systems Become Available Across US Laboratories

Siemens Healthineers’ CN-3000 and CN-6000 automated hemostasis analyzers are now available for patient testing in the United States. Read more
17 Sep 2026 | Hematology
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Guidelines recommend targeted CLIA updates to ensure safe, validated AI use in clinical labs, with risk-based oversight. Read more
17 Sep 2026 | Technology
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

A tumor budding-based grading system identifies high-risk patients after lung squamous cell carcinoma surgery. Read more
17 Sep 2026 | Pathology
Image: A very high magnification micrograph of Gaucher disease, the most common lysosomal disorder (Image Credit: Nephron/Wikimedia Commons, CC BY-SA 3.0)

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework

A new classification framework expands lysosomal disorders to 108, enhancing diagnosis and informing screening and trials. Read more
17 Sep 2026 | BioResearch
Image: Acute myeloid leukemia is an aggressive blood cancer in which relapse remains a major challenge, making MRD detection critical for risk assessment and treatment planning (Image Credit: Shutterstock)

Variation in AML Residual Disease Testing Prompts Push for Standardization

Findings show measurable residual disease flow cytometry results for acute myeloid leukemia vary widely. Read more
17 Sep 2026 | Hematology
Image Credit: Adobe Stock

CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

CAP has introduced revisions to 14 Cancer Protocols to align cancer reporting with evolving WHO classifications. Read more
17 Sep 2026 | Pathology
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

An AI-enabled multi-biomarker blood test detects early-stage pancreatic cancer (87% sensitivity) and flags high-grade dysplasia. Read more
16 Sep 2026 | Clinical Chem.
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

A nanoparticle-based blood test detects amoxicillin/penicillin allergy with 98% sensitivity. Read more
16 Sep 2026 | Microbiology
Image Credit: Diane E. MacDougall et al., FIND Lp(a) Machine Learning Model: Targeted Screening Enrichment of Elevated Lipoprotein(a) in Atherosclerotic Cardiovascular Disease, JACC: Advances (2026). DOI: 10.1016/j.jacadv.2026.103114

Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)

An AI approach leverages EMR data to target Lp(a) screening, finding ASCVD patients over 2x likelier to have high levels. Read more
16 Sep 2026 | Clinical Chem.
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte has acquired Convergent Genomics, adding its UroAmp urinary tumor DNA platform to its urology diagnostics portfolio. Read more
16 Sep 2026 | Industry
Image: Researchers from Korea University investigated whether changes in plasma p-tau217 could provide an early, minimally invasive measure of biological response to lecanemab in people with early Alzheimer’s disease (Image Credit: Prof. Sung Hoon Kang from Korea University College of Medicine)

Blood Biomarker May Help Monitor Early Response to Lecanemab in Alzheimer’s Disease

A blood-based p-tau217 test tracks early response to lecanemab and aligns with slower cognitive decline in early AD. Read more
16 Sep 2026 | Clinical Chem.
Image: Concentriq AP-Dx supports primary diagnosis from digital pathology slides and is FDA-cleared, Health Canada-licensed, and CE-marked under the EU IVDR. (Photo courtesy of Proscia)

Unilabs Expands Digital Pathology Across European Network with Proscia Platform

Proscia announced that Unilabs is leveraging the Concentriq platform to advance digital pathology across its European network Read more
16 Sep 2026 | Industry
Image: Under the theme “From Tissue to Answer”, the launch of VisiOmics anchors a comprehensive pathology portfolio spanning tissue and molecular pathology (Photo courtesy of MGI Tech Co., Ltd.)

MGI Launches Automated Multiplex Tissue Staining and Imaging System at ECP 2026

MGI Tech introduced VisiOmics (PMIF-20RS), a fully automated multiplex immunofluorescence staining and imaging system, at ECP 2026 in Stockholm. Read more
16 Sep 2026 | Industry

Channels

Clinical Chemistry

view channel
Childhood Blood Biomarkers May Reveal Early Heart, Kidney, and Metabolic Risks
Blood Biomarker Study Reveals Early Signals of Future Cognitive Difficulties
New Reference Material Aims to Improve Comparability of Angiotensin II Testing
Image: Researchers identified a naturally occurring brain-related antibody linked to lower depression and PTSD symptoms after TBI (Image Credit: Adobe Stock)

Blood Antibody Linked to Lower Depression and PTSD Symptoms After Brain Injury

Traumatic brain injury (TBI) is associated with a two- to four-fold increase in risk for depression, anxiety, and post‑traumatic stress disorder (PTSD), yet many patients do not develop psychiatric symptoms.... Read more

Molecular Diagnostics

view channel
Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset
Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants
40-Gene Test Validated for High-Risk Squamous Cell Carcinoma
Image Credit: Adobe Stock

Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers

Early detection of stage I solid cancers remains a significant unmet clinical need. Liquid biopsy approaches that can distinguish tumor-derived signals from background cell-free DNA are therefore drawing... Read more

Hematology

view channel
Borderline Anemia May Carry Higher Risk Than Current Thresholds Suggest
Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy
New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome
Image: Antibodies against platelet factor 4 can trigger life-threatening clots if not identified quickly (Image Credit: 123RF)

Hidden Molecular Mechanism Behind HIT Blood-Clotting Disorder Revealed

Immune-mediated thrombosis following heparin therapy can be sudden and severe, creating urgent diagnostic challenges. In heparin-induced thrombocytopenia (HIT), antibodies against platelet factor 4 (PF4)... Read more

Immunology

view channel
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID...
Gut “Memory” May Explain Why IBD Flares Return
Image Credit: Adobe Stock

New Cellular Map May Help Predict Crohn’s Disease Course in Children

Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more

Microbiology

view channel
Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures
Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics
Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification
Image: Graphical Abstract (Zeyang Shen et al., Shotgun Metagenomics Reveals Skin Microbiome Composition and Function in Infant Atopic Disease, Allergy, 2026. DOI: 10.1111/all.70449)

Infant Skin Microbiome Show Links to Later Eczema and Food Allergies

Eczema, or atopic dermatitis, and food allergies often begin in infancy and are among the earliest stages of the atopic march. Atopic dermatitis alone can affect up to 20% of children, yet objective indicators... Read more

Pathology

view channel
Hybrid Computational Imaging Method Improves Digital Pathology Resolution
FDA Clearance Expands Digital Pathology Options for Clinical Laboratories
Label-Free Imaging Reveals Hidden Immune Activity in Blood Samples
Image: The workflow analyzes slides already generated during routine care, providing added prognostic information without requiring another tissue test (Image Credit: Shutterstock)

AI Spatial Analysis of Routine Slides Helps Predict Pancreatic Cancer Recurrence

Predicting which patients with pancreatic cancer will recur after treatment and surgery remains challenging. Pathology evaluation typically measures residual tumor burden, but recent work found that tumor... Read more

Technology

view channel
New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic ...
Autonomous Robotic System Receives FDA Authorization for Blood Collection
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Blood-Based Neurology Biomarker Assays Authorized for Use in Brazil
Sepsis Diagnostics Market Growth Fueled by Faster Pathogen Detection Needs
Project Advances Single-Cell Diagnostic Test for Triple-Negative Breast Cancer
Image: Aiforia and Stratipath will integrate Stratipath Breast into the Aiforia Clinical Platform, giving laboratories access to both companies’ breast cancer AI tools in one workflow (Photo courtesy of Aiforia)

Digital Pathology Partnership Integrates Breast Cancer Diagnostic and Prognostic Tools

Breast cancer diagnostics rely on reproducible histological grading and timely interpretation of immunohistochemical biomarkers to guide therapy. Access to prognostic risk profiling can be limited by long... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
Industry
BioResearch
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
ADLM WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica

 

ADLM Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE